Skip to main content
4SC AG logo

4SC AG — Investor Relations & Filings

Ticker · VSC ISIN · DE000A3E5C40 LEI · 391200QOKN7LGVP0RQ86 F Manufacturing
Open in API
Filings indexed 719 across all filing types
Latest filing 2013-09-13 Regulatory Filings
Country DE Germany
Listing F VSC

About 4SC AG

https://www.4sc.com/

4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.

Recent filings

Filing Released Lang Actions
Press Release: 4SC presents results from analysis of biomarkers and prognostic factors in Phase II SHELTER trial with resminostat in advanced liver cancer (HCC)
Regulatory Filings Classification · 95% confidence The document is a 'Press Release' dated September 13, 2013, announcing the presentation of results from a Phase II clinical trial (SHELTER trial) concerning biomarkers and survival factors related to the drug resminostat in advanced liver cancer (HCC). It details scientific findings, mentions a patent application, and discusses plans for a future pivotal clinical program. This content is characteristic of an announcement detailing scientific or clinical progress, which often accompanies or precedes a formal financial filing, but the document itself is a press release reporting scientific/clinical data. Since it is not a formal regulatory report (like 10-K, IR, or AR), nor a specific announcement like a dividend (DIV) or management change (MANG), it falls best under the general category for corporate news that doesn't fit elsewhere, which is Regulatory Filings (RNS), or potentially Investor Presentation (IP) if it were the presentation itself. Given the format is a press release detailing clinical trial results and future development plans, RNS serves as the most appropriate general regulatory/corporate news category when specific categories like ER or CT do not apply. The document length is substantial (17k chars), indicating it is the full content, not just a brief announcement of a report (ruling out RPA).
2013-09-13 English
Q2 Report 2013
Interim / Quarterly Report Classification · 100% confidence The document is titled 'consolidated half-year financial report' and covers the period ending 30 June 2013. It contains substantive financial data, including revenue, operating profit/loss, earnings per share, and equity figures for the 6-month period. It also provides a detailed business review, product pipeline updates, and management commentary. As it is a comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2013
2013-08-20 English
Press Release: 4SC reports second quarter 2013 financial results
Earnings Release Classification · 100% confidence The document is explicitly titled "Press Release: 4SC reports second quarter 2013 financial results" and details consolidated revenue, loss reduction, operating expenses, and cash flow for the first six months and second quarter of 2013. This content structure—presenting key financial metrics for a specific reporting period (H1/Q2) immediately following the period end—is characteristic of an Earnings Release (ER). While it contains detailed financial information, it is presented as a press release announcing the results, rather than the comprehensive, formal filing (like a 10-Q or 10-K) or a standalone management discussion (MDA). The focus is on the immediate release of period results. H1 2013
2013-08-08 English
Jahresabschluss zum Geschäftsjahr vom 01.01.2012 bis zum 31.12.2012
Audit Report / Information Classification · 98% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for 4SC AG for the fiscal year 2012. It contains a balance sheet (Bilanz), profit and loss statement (Gewinn- und Verlustrechnung), and notes (Anhang). This constitutes the core financial components of an annual report. While it is not the full glossy annual report (which would include management commentary and corporate governance sections), it is the official statutory financial reporting document for the year, which falls under the 10-K category in this taxonomy. FY 2012
2013-08-06 German
Announcement: 4SC to host conference call on 8 August 2013 to present half year results 2013
Report Publication Announcement Classification · 99% confidence The document is a short announcement (4044 characters) dated August 1, 2013. The headline explicitly states that the company "will announce second quarter results 2013 of the 4SC Group and publish the company’s half year report 2013 on 8 August 2013." It then details the logistics for a conference call to discuss these results. Since the document itself is not the comprehensive half-year report (IR) or the initial earnings release (ER), but rather an announcement about the *publication* of those reports and the associated conference call, it fits the definition of a Report Publication Announcement (RPA). It announces when and how the actual reports will be made available.
2013-08-01 English
Press Release: 4SC's partner Yakult Honsha starts clinical Phase I/II study with cancer compound resminostat in non-small-cell lung cancer (NSCLC) in Japan
Regulatory Filings Classification · 100% confidence The document is titled "Press Release" and announces that 4SC's partner, Yakult Honsha, has started a clinical Phase I/II study with the cancer compound resminostat in Japan. It details the study design, endpoints, and provides background information on the drug and the indication. This type of announcement, detailing operational progress (like starting a clinical trial) rather than comprehensive financial results (like a 10-K or ER) or mandatory regulatory filings, is best classified as a general corporate announcement. Since it is a press release detailing operational/development news and does not fit the specific categories like ER, IR, or CAP, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate news disseminated via official channels (like DGAP in this case). The document length (11,592 chars) is substantial enough that it is not merely an announcement *of* a report, but the report itself (a press release).
2013-07-25 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.